Cargando…

Weak Cytotoxic T Cells Activation Predicts Low-Grade Dysplasia Persistence in Ulcerative Colitis

In patients with ulcerative colitis (UC), dysplasia develops in 10%–20% of cases. The persistence of low-grade dysplasia (LGD) in UC in 2 consecutive observations is still an indication for restorative proctocolectomy. Our hypothesis is that in the case of weak cytotoxic activation, dysplasia persis...

Descripción completa

Detalles Bibliográficos
Autores principales: Kotsafti, Andromachi, D'Incà, Renata, Scarpa, Melania, Fassan, Matteo, Angriman, Imerio, Mescoli, Claudia, Bortoli, Nicolò, Brun, Paola, Bardini, Romeo, Rugge, Massimo, Savarino, Edoardo, Zingone, Fabiana, Castoro, Carlo, Castagliuolo, Ignazio, Scarpa, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708661/
https://www.ncbi.nlm.nih.gov/pubmed/31343468
http://dx.doi.org/10.14309/ctg.0000000000000061
_version_ 1783446040800657408
author Kotsafti, Andromachi
D'Incà, Renata
Scarpa, Melania
Fassan, Matteo
Angriman, Imerio
Mescoli, Claudia
Bortoli, Nicolò
Brun, Paola
Bardini, Romeo
Rugge, Massimo
Savarino, Edoardo
Zingone, Fabiana
Castoro, Carlo
Castagliuolo, Ignazio
Scarpa, Marco
author_facet Kotsafti, Andromachi
D'Incà, Renata
Scarpa, Melania
Fassan, Matteo
Angriman, Imerio
Mescoli, Claudia
Bortoli, Nicolò
Brun, Paola
Bardini, Romeo
Rugge, Massimo
Savarino, Edoardo
Zingone, Fabiana
Castoro, Carlo
Castagliuolo, Ignazio
Scarpa, Marco
author_sort Kotsafti, Andromachi
collection PubMed
description In patients with ulcerative colitis (UC), dysplasia develops in 10%–20% of cases. The persistence of low-grade dysplasia (LGD) in UC in 2 consecutive observations is still an indication for restorative proctocolectomy. Our hypothesis is that in the case of weak cytotoxic activation, dysplasia persists. We aimed to identify possible immunological markers of LGD presence and persistence. METHODS: We prospectively enrolled 112 UC patients who underwent screening colonoscopy (T0) who had biopsies taken from their sigmoid colon. Ninety of them had at least a second colonoscopy (T1) with biopsies taken in the sigmoid colon and 8 patients had dysplasia in both examinations suggesting a persistence of LGD in their colon. Immunohistochemistry and real time polymerase chain reaction for CD4, CD69, CD107, and CD8β messenger RNA (mRNA) expression and flow cytometry for epithelial cells expressing CD80 or HLA avidin-biotin complex were performed. Non-parametric statistics, receiver operating characteristic curves analysis, and logistic multiple regression analysis were used. RESULTS: Thirteen patients had LGD diagnosed at T0. The mucosal mRNA expression of CD4, CD69, and CD8β was significantly lower than in patients without dysplasia (P = 0.033, P = 0.046 and P = 0.007, respectively). A second colonoscopy was performed in 90 patients after a median follow-up of 17 (12–25) months and 14 of the patients were diagnosed with LGD. In these patients, CD8β mRNA expression at T0 was significantly lower in patients without dysplasia (P = 0.004). A multivariate survival analysis in a model including CD8β mRNA levels and age >50 demonstrated that both items were independent predictors of dysplasia at follow-up (hazard ratio [HR] = 0.47 [95% confidence interval [CI]: 0.26–0.86], P = 0.014, and HR = 13.32 [95% CI: 1.72–102.92], P = 0.013). DISCUSSION: These data suggest a low cytotoxic T cell activation in the colonic mucosa of UC patients who do not manage to clear dysplasia. Thus, low level of CD8β mRNA expression in non-dysplastic colonic mucosa might be considered in future studies about the decision making of management of LGD in UC.
format Online
Article
Text
id pubmed-6708661
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer
record_format MEDLINE/PubMed
spelling pubmed-67086612019-10-10 Weak Cytotoxic T Cells Activation Predicts Low-Grade Dysplasia Persistence in Ulcerative Colitis Kotsafti, Andromachi D'Incà, Renata Scarpa, Melania Fassan, Matteo Angriman, Imerio Mescoli, Claudia Bortoli, Nicolò Brun, Paola Bardini, Romeo Rugge, Massimo Savarino, Edoardo Zingone, Fabiana Castoro, Carlo Castagliuolo, Ignazio Scarpa, Marco Clin Transl Gastroenterol Article In patients with ulcerative colitis (UC), dysplasia develops in 10%–20% of cases. The persistence of low-grade dysplasia (LGD) in UC in 2 consecutive observations is still an indication for restorative proctocolectomy. Our hypothesis is that in the case of weak cytotoxic activation, dysplasia persists. We aimed to identify possible immunological markers of LGD presence and persistence. METHODS: We prospectively enrolled 112 UC patients who underwent screening colonoscopy (T0) who had biopsies taken from their sigmoid colon. Ninety of them had at least a second colonoscopy (T1) with biopsies taken in the sigmoid colon and 8 patients had dysplasia in both examinations suggesting a persistence of LGD in their colon. Immunohistochemistry and real time polymerase chain reaction for CD4, CD69, CD107, and CD8β messenger RNA (mRNA) expression and flow cytometry for epithelial cells expressing CD80 or HLA avidin-biotin complex were performed. Non-parametric statistics, receiver operating characteristic curves analysis, and logistic multiple regression analysis were used. RESULTS: Thirteen patients had LGD diagnosed at T0. The mucosal mRNA expression of CD4, CD69, and CD8β was significantly lower than in patients without dysplasia (P = 0.033, P = 0.046 and P = 0.007, respectively). A second colonoscopy was performed in 90 patients after a median follow-up of 17 (12–25) months and 14 of the patients were diagnosed with LGD. In these patients, CD8β mRNA expression at T0 was significantly lower in patients without dysplasia (P = 0.004). A multivariate survival analysis in a model including CD8β mRNA levels and age >50 demonstrated that both items were independent predictors of dysplasia at follow-up (hazard ratio [HR] = 0.47 [95% confidence interval [CI]: 0.26–0.86], P = 0.014, and HR = 13.32 [95% CI: 1.72–102.92], P = 0.013). DISCUSSION: These data suggest a low cytotoxic T cell activation in the colonic mucosa of UC patients who do not manage to clear dysplasia. Thus, low level of CD8β mRNA expression in non-dysplastic colonic mucosa might be considered in future studies about the decision making of management of LGD in UC. Wolters Kluwer 2019-07-23 /pmc/articles/PMC6708661/ /pubmed/31343468 http://dx.doi.org/10.14309/ctg.0000000000000061 Text en © 2019 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Article
Kotsafti, Andromachi
D'Incà, Renata
Scarpa, Melania
Fassan, Matteo
Angriman, Imerio
Mescoli, Claudia
Bortoli, Nicolò
Brun, Paola
Bardini, Romeo
Rugge, Massimo
Savarino, Edoardo
Zingone, Fabiana
Castoro, Carlo
Castagliuolo, Ignazio
Scarpa, Marco
Weak Cytotoxic T Cells Activation Predicts Low-Grade Dysplasia Persistence in Ulcerative Colitis
title Weak Cytotoxic T Cells Activation Predicts Low-Grade Dysplasia Persistence in Ulcerative Colitis
title_full Weak Cytotoxic T Cells Activation Predicts Low-Grade Dysplasia Persistence in Ulcerative Colitis
title_fullStr Weak Cytotoxic T Cells Activation Predicts Low-Grade Dysplasia Persistence in Ulcerative Colitis
title_full_unstemmed Weak Cytotoxic T Cells Activation Predicts Low-Grade Dysplasia Persistence in Ulcerative Colitis
title_short Weak Cytotoxic T Cells Activation Predicts Low-Grade Dysplasia Persistence in Ulcerative Colitis
title_sort weak cytotoxic t cells activation predicts low-grade dysplasia persistence in ulcerative colitis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708661/
https://www.ncbi.nlm.nih.gov/pubmed/31343468
http://dx.doi.org/10.14309/ctg.0000000000000061
work_keys_str_mv AT kotsaftiandromachi weakcytotoxictcellsactivationpredictslowgradedysplasiapersistenceinulcerativecolitis
AT dincarenata weakcytotoxictcellsactivationpredictslowgradedysplasiapersistenceinulcerativecolitis
AT scarpamelania weakcytotoxictcellsactivationpredictslowgradedysplasiapersistenceinulcerativecolitis
AT fassanmatteo weakcytotoxictcellsactivationpredictslowgradedysplasiapersistenceinulcerativecolitis
AT angrimanimerio weakcytotoxictcellsactivationpredictslowgradedysplasiapersistenceinulcerativecolitis
AT mescoliclaudia weakcytotoxictcellsactivationpredictslowgradedysplasiapersistenceinulcerativecolitis
AT bortolinicolo weakcytotoxictcellsactivationpredictslowgradedysplasiapersistenceinulcerativecolitis
AT brunpaola weakcytotoxictcellsactivationpredictslowgradedysplasiapersistenceinulcerativecolitis
AT bardiniromeo weakcytotoxictcellsactivationpredictslowgradedysplasiapersistenceinulcerativecolitis
AT ruggemassimo weakcytotoxictcellsactivationpredictslowgradedysplasiapersistenceinulcerativecolitis
AT savarinoedoardo weakcytotoxictcellsactivationpredictslowgradedysplasiapersistenceinulcerativecolitis
AT zingonefabiana weakcytotoxictcellsactivationpredictslowgradedysplasiapersistenceinulcerativecolitis
AT castorocarlo weakcytotoxictcellsactivationpredictslowgradedysplasiapersistenceinulcerativecolitis
AT castagliuoloignazio weakcytotoxictcellsactivationpredictslowgradedysplasiapersistenceinulcerativecolitis
AT scarpamarco weakcytotoxictcellsactivationpredictslowgradedysplasiapersistenceinulcerativecolitis